Rebecca J Cox1, Karl A Brokstad2, Florian Krammer3, Nina Langeland4. 1. Influenza Centre, University of Bergen, Bergen, Norway; Department of Microbiology, Haukeland University Hospital, Bergen, Norway. Electronic address: rebecca.cox@uib.no. 2. Broegelemann Research Laboratory, University of Bergen, Bergen, Norway. 3. Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. Department of Clinical Sciences, University of Bergen, Bergen, Norway; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
We read with interest the Article by Qifang Bi and colleagues, in which they reported a household secondary attack rate, as detected by repeated RT-PCR tests, of approximately 11%. We have found substantially higher attacks rates in western Norway through detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The first case of COVID-19 in Norway was identified in Bergen on Feb 28, 2020, before the outbreak was declared a pandemic, allowing rigorous testing of suspected cases before and during the rise in confirmed cases. All suspected COVID-19 cases in the peak period between Feb 28 and April 4 were referred to the Bergen municipality emergency room for centralised evaluation and testing according to a strict exposure likelihood algorithm, allowing an overview of the early virus spread in the population. If a family was exposed, only the index case was tested for SARS-CoV-2 infection. Both cases and household members were tested for specific antibodies to the receptor binding domain of SARS-CoV-2, as described by Stadlbauer and colleagues, at 6 weeks after the index patient tested positive by RT-PCR.Of 158 cases, 125 (79%) tested positive for antibodies and 12 (8%) were defined as borderline. In 77 household members, 24 (31%) tested positive and two (3%) were borderline. Our results show that detection of seroconversion might provide a more accurate picture of attack rates in households than intermittent RT-PCR testing.
Authors: Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi H O Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel S Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Charlotte Cunningham-Rundles; Philip L Felgner; Thomas Moran; Adolfo García-Sastre; Daniel Caplivski; Allen C Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi M Hepojoki; Viviana Simon; Florian Krammer Journal: Nat Med Date: 2020-05-12 Impact factor: 53.440
Authors: Kristin G-I Mohn; Geir Bredholt; Fan Zhou; Anders Madsen; Therese B Onyango; Elisabeth B Fjelltveit; Sarah L Jalloh; Karl A Brokstad; Diego Cantoni; Martin Mayora-Neto; Nigel Temperton; Nina Langeland; Rebecca J Cox Journal: PLoS One Date: 2022-02-22 Impact factor: 3.240